It also alleviated atopic dermatitis symptoms in vivo by inhibiting nuclear factor kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) signaling and cytokine production (Choi et al. 2018). The gene discussed is NFKB1; the disease is atopic eczema.